Improving Clinician and Patient Adherence to Guideline-Recommended Antiplatelet Therapy in ACS: An Interactive Serial-Learning Initiative for Managed Care

TeleWeb with Live Q&A Sessions

Register Now

Wednesday, February 24 2 to 3 pm ET Thursday, February 25 1 to 2 pm ET    Friday, February 26 Noon to 1 pm ET Tuesday, March 2 3 to 4 pm ET

Jointly sponsored by North American Center for Continuing Medical Education, LLC and Horizon CME

Presenters/Q&A Cohosts

Christopher Cannon, MD
Senior Investigator, TIMI Study Group/Brigham & Women’s Hospital
Associate Professor of Medicine
Harvard Medical School
Associate Physician
Cardiovascular Division, Brigham & Women’s Hospital
Boston, Massachusetts

Ty J. Gluckman, MD, FACC
Director, Coronary Care Unit
Providence St. Vincent Heart & Vascular Institute
Portland, Oregon

Q&A Cohost

William J. Cardarelli, PharmD
Director of Pharmacy
Atrius Health
Harvard Vanguard Medical Associates
Watertown, Massachusetts

Learning Objectives

• Outline the guideline-based role of antiplatelet therapy in the prevention of coronary attacks in patients with acute coronary syndromes (ACS)
• Summarize the clinical profiles of current and emerging antiplatelet therapies
• Describe the cost-effectiveness of antiplatelet therapy in patients with ACS
• Identify barriers to clinician and patient adherence to guideline-based antiplatelet therapy and implement strategies to overcome them

Target Audience

This activity is designed for managed markets physicians and pharmacists. 

The Princeton TeleWeb Series

The Princeton TeleWeb Series provides participants with the opportunity to enhance their learning experience via synchronized slide presentation and live real-time polling questions.

To receive live credit for this activity, all participants must access the audio lecture and Q&A portions of the program by phone. To participate, dial toll-free 800-803-7101 approximately 5 minutes before the scheduled time of the TeleWeb. Upon calling in, provide the activity code, ACS.

To participate in the interactive presentation portion of the TeleWeb activity, visit www.naccme.com and click the “Access Live TeleWeb Activity” link in the spotlight box.

Participants without access to a computer or internet connectivity may access the activity via phone only. Printable slides will be available at www.naccme.com prior to the TeleWeb for those accessing the activity via phone only.

To be eligible for documentation of credit, participants must attend a full TeleWeb event, complete the 10-question online post-test with a score of 70% or better, and complete the evaluation form. After successful completion of the post-test and evaluation form online at www.naccme.com, participants may immediately print their documentation of credit.

Please call 609-371-1137 or e-mail ascarnici@naccme.com with any questions regarding TeleWeb technical requirements or accessibility.

To be eligible for credit for the live version of this activity, completed post-tests must be submitted online by March 16, 2010.

There is no fee associated with this activity.

This educational activity is a knowledge-based activity.

Hardware/Software Requirements

All educational activities are accessible via a computer with 650 MHz PC, 128 MB RAM, Windows or MAC operating system, Internet Explorer, Netscape, or Safari browsers. Windows Media Player, sound card, and speakers are required for streamed audio. Flash Player, sound card, and speakers are required for video programs. A PDF reader is required for print publications. Please direct technical questions to webmaster@naccme.com.

CME Accreditation

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of North American Center for Continuing Medical Education, LLC (NACCME) and Horizon CME. NACCME is accredited by the ACCME to provide continuing medical education for physicians.

NACCME designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CPE Accreditation

North American Center for Continuing Medical Education, LLC (NACCME) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity is approved for 1 contact hour (0.1 CEU) of continuing pharmacy education (276-999-10-002-L01-P).

Independent Clinical Reviewer: Luis Gruberg, MD, FACC, Director, Cardiac Catheterization Laboratories, Professor of Medicine, Division of Cardiology, Stony Brook University, Stony Brook, New York

Planning Committee

The planning committee comprises Christopher Cannon, MD, Ty J. Gluckman, MD, FACC, Luis Gruberg, MD, FACC; Elizabeth Hill, Brian Lee, PharmD, Horizon CME; Kristin Dickie, Mary Johnson, Mike Kearney, Randy Robbin, John Savage, and Jessica Steuerman, NACCME.

Financial Disclosure and Conflicts of Interest  

According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.

All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.

The faculty has reported the following:

Dr. Cannon: Grant/research support—Accumetrics, AstaZeneca, Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership, GlaxoSmithKline, Intekrin Therapeutics, Merck & Co, Inc, Novartis, Takeda Pharmaceuticals North American, Inc; Clinical advisor—Automedics Medical Systems
Dr. Gluckman: Promotional speakers bureau—Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership, Eli Lilly/Daiichi Sankyo Partnership
Dr. Gruberg: Promotional speakers bureau—Abbott, Eli Lilly and Company
Dr. Cardarelli disclosed no relevant financial relationships with any commercial interests.

Ms. Dickie, Ms. Hill, Ms. Johnson, Mr. Kearney, Dr. Lee, Mr. Robbin, Mr. Savage, and Ms. Steuerman have disclosed no relevant financial relationships with any commercial interests.

NACCME requires faculty to inform participants whenever off-label/unapproved uses of drugs and/or devices are discussed in their presentations.

The faculty has disclosed that the following off-label/unapproved use(s) of drugs and/or devices will be discussed: The use of ticagrelor for the treatment of ACS.

Privacy Policy

NACCME and Horizon CME protect the privacy of personal and other information regarding participants, educational partners, and joint sponsors. NACCME, Horizon CME, and our joint sponsors will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.

NACCME and Horizon CME maintain physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2010 by North American Center for Continuing Medical Education, LLC and Horizon CME. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education and Horizon CME.

Grant Support

Supported by an educational grant from Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership

Representatives of the granting organization may not register on behalf of participants.

Register Now